Article
ResMAP-a saturation mutagenesis platform enabling parallel profiling of target-specific resistance-conferring mutations in Plasmodium.
mBio - 16 Oct 2024
Wall Richard J, MacGowan Stuart A, Hallyburton Irene, Syed Aisha J, Ajay Castro Sowmya, Dey Gourav, Milne Rachel, Patterson Stephen, Phelan Jody, Wiedemar Natalie, Wyllie Susan
Abstract excerpt
New and improved drugs are required for the treatment and ultimate eradication of malaria. The efficacy of front-line therapies is now threatened by emerging drug resistance; thus, new tools to support the development of drugs with a lower propensity for resistance are needed. Here, we describe the development of a RESistance Mapping And Profiling (ResMAP) platform for the identification of resistance-conferring...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
